1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oxaliplatin API Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-2D7798
Home | Market Reports | Business & Industrial| Chemicals Industry
Global and China Oxaliplatin API Market Insights Forecast to 2027
BUY CHAPTERS

Global Oxaliplatin API Market Research Report 2025

Code: QYRE-Auto-2D7798
Report
July 2025
Pages:99
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Oxaliplatin API Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Oxaliplatin API Market

Oxaliplatin API Market

The global market for Oxaliplatin API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The appearance is white or similar white powder, has the anti-tumor, the inhibition cell mitosis function. The molecular formula is C16H16ClN3O3S, and CAS number is 61825-94-3.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oxaliplatin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oxaliplatin API.
The Oxaliplatin API market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oxaliplatin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oxaliplatin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Oxaliplatin API Market Report

Report Metric Details
Report Name Oxaliplatin API Market
CAGR 5%
by Type
  • Purity ≥ 98 %
  • Purity ≥ 99 %
by Application
  • Oxaliplatin Injection
  • Other
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Scion Pharm Taiwan, Acebright, Sai Phytoceuticals, Nischem International, Polymed Therapeutics, Fresenius Kabi Oncology, Tapi Teva, Heraeus, Shilpa Medicare Limited, Vinkem Labs, Chem Genix, Cipla, Qilu Pharmaceutial, VUAB Pharma, Berr Chemical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Oxaliplatin API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Oxaliplatin API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Oxaliplatin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Oxaliplatin API Market report?

Ans: The main players in the Oxaliplatin API Market are Scion Pharm Taiwan, Acebright, Sai Phytoceuticals, Nischem International, Polymed Therapeutics, Fresenius Kabi Oncology, Tapi Teva, Heraeus, Shilpa Medicare Limited, Vinkem Labs, Chem Genix, Cipla, Qilu Pharmaceutial, VUAB Pharma, Berr Chemical

What are the Application segmentation covered in the Oxaliplatin API Market report?

Ans: The Applications covered in the Oxaliplatin API Market report are Oxaliplatin Injection, Other

What are the Type segmentation covered in the Oxaliplatin API Market report?

Ans: The Types covered in the Oxaliplatin API Market report are Purity ≥ 98 %, Purity ≥ 99 %

1 Oxaliplatin API Market Overview
1.1 Product Definition
1.2 Oxaliplatin API by Type
1.2.1 Global Oxaliplatin API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Purity ≥ 98 %
1.2.3 Purity ≥ 99 %
1.3 Oxaliplatin API by Application
1.3.1 Global Oxaliplatin API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Oxaliplatin Injection
1.3.3 Other
1.4 Global Market Growth Prospects
1.4.1 Global Oxaliplatin API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Oxaliplatin API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Oxaliplatin API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Oxaliplatin API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Oxaliplatin API Production Market Share by Manufacturers (2020-2025)
2.2 Global Oxaliplatin API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Oxaliplatin API, Industry Ranking, 2023 VS 2024
2.4 Global Oxaliplatin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Oxaliplatin API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Oxaliplatin API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Oxaliplatin API, Product Offered and Application
2.8 Global Key Manufacturers of Oxaliplatin API, Date of Enter into This Industry
2.9 Oxaliplatin API Market Competitive Situation and Trends
2.9.1 Oxaliplatin API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Oxaliplatin API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Oxaliplatin API Production by Region
3.1 Global Oxaliplatin API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Oxaliplatin API Production Value by Region (2020-2031)
3.2.1 Global Oxaliplatin API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Oxaliplatin API by Region (2026-2031)
3.3 Global Oxaliplatin API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Oxaliplatin API Production Volume by Region (2020-2031)
3.4.1 Global Oxaliplatin API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Oxaliplatin API by Region (2026-2031)
3.5 Global Oxaliplatin API Market Price Analysis by Region (2020-2025)
3.6 Global Oxaliplatin API Production and Value, Year-over-Year Growth
3.6.1 North America Oxaliplatin API Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Oxaliplatin API Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Oxaliplatin API Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Oxaliplatin API Production Value Estimates and Forecasts (2020-2031)
4 Oxaliplatin API Consumption by Region
4.1 Global Oxaliplatin API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Oxaliplatin API Consumption by Region (2020-2031)
4.2.1 Global Oxaliplatin API Consumption by Region (2020-2025)
4.2.2 Global Oxaliplatin API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Oxaliplatin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Oxaliplatin API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Oxaliplatin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Oxaliplatin API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Oxaliplatin API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Oxaliplatin API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Oxaliplatin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Oxaliplatin API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Oxaliplatin API Production by Type (2020-2031)
5.1.1 Global Oxaliplatin API Production by Type (2020-2025)
5.1.2 Global Oxaliplatin API Production by Type (2026-2031)
5.1.3 Global Oxaliplatin API Production Market Share by Type (2020-2031)
5.2 Global Oxaliplatin API Production Value by Type (2020-2031)
5.2.1 Global Oxaliplatin API Production Value by Type (2020-2025)
5.2.2 Global Oxaliplatin API Production Value by Type (2026-2031)
5.2.3 Global Oxaliplatin API Production Value Market Share by Type (2020-2031)
5.3 Global Oxaliplatin API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Oxaliplatin API Production by Application (2020-2031)
6.1.1 Global Oxaliplatin API Production by Application (2020-2025)
6.1.2 Global Oxaliplatin API Production by Application (2026-2031)
6.1.3 Global Oxaliplatin API Production Market Share by Application (2020-2031)
6.2 Global Oxaliplatin API Production Value by Application (2020-2031)
6.2.1 Global Oxaliplatin API Production Value by Application (2020-2025)
6.2.2 Global Oxaliplatin API Production Value by Application (2026-2031)
6.2.3 Global Oxaliplatin API Production Value Market Share by Application (2020-2031)
6.3 Global Oxaliplatin API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Scion Pharm Taiwan
7.1.1 Scion Pharm Taiwan Oxaliplatin API Company Information
7.1.2 Scion Pharm Taiwan Oxaliplatin API Product Portfolio
7.1.3 Scion Pharm Taiwan Oxaliplatin API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Scion Pharm Taiwan Main Business and Markets Served
7.1.5 Scion Pharm Taiwan Recent Developments/Updates
7.2 Acebright
7.2.1 Acebright Oxaliplatin API Company Information
7.2.2 Acebright Oxaliplatin API Product Portfolio
7.2.3 Acebright Oxaliplatin API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Acebright Main Business and Markets Served
7.2.5 Acebright Recent Developments/Updates
7.3 Sai Phytoceuticals
7.3.1 Sai Phytoceuticals Oxaliplatin API Company Information
7.3.2 Sai Phytoceuticals Oxaliplatin API Product Portfolio
7.3.3 Sai Phytoceuticals Oxaliplatin API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Sai Phytoceuticals Main Business and Markets Served
7.3.5 Sai Phytoceuticals Recent Developments/Updates
7.4 Nischem International
7.4.1 Nischem International Oxaliplatin API Company Information
7.4.2 Nischem International Oxaliplatin API Product Portfolio
7.4.3 Nischem International Oxaliplatin API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Nischem International Main Business and Markets Served
7.4.5 Nischem International Recent Developments/Updates
7.5 Polymed Therapeutics
7.5.1 Polymed Therapeutics Oxaliplatin API Company Information
7.5.2 Polymed Therapeutics Oxaliplatin API Product Portfolio
7.5.3 Polymed Therapeutics Oxaliplatin API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Polymed Therapeutics Main Business and Markets Served
7.5.5 Polymed Therapeutics Recent Developments/Updates
7.6 Fresenius Kabi Oncology
7.6.1 Fresenius Kabi Oncology Oxaliplatin API Company Information
7.6.2 Fresenius Kabi Oncology Oxaliplatin API Product Portfolio
7.6.3 Fresenius Kabi Oncology Oxaliplatin API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Fresenius Kabi Oncology Main Business and Markets Served
7.6.5 Fresenius Kabi Oncology Recent Developments/Updates
7.7 Tapi Teva
7.7.1 Tapi Teva Oxaliplatin API Company Information
7.7.2 Tapi Teva Oxaliplatin API Product Portfolio
7.7.3 Tapi Teva Oxaliplatin API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Tapi Teva Main Business and Markets Served
7.7.5 Tapi Teva Recent Developments/Updates
7.8 Heraeus
7.8.1 Heraeus Oxaliplatin API Company Information
7.8.2 Heraeus Oxaliplatin API Product Portfolio
7.8.3 Heraeus Oxaliplatin API Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Heraeus Main Business and Markets Served
7.8.5 Heraeus Recent Developments/Updates
7.9 Shilpa Medicare Limited
7.9.1 Shilpa Medicare Limited Oxaliplatin API Company Information
7.9.2 Shilpa Medicare Limited Oxaliplatin API Product Portfolio
7.9.3 Shilpa Medicare Limited Oxaliplatin API Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Shilpa Medicare Limited Main Business and Markets Served
7.9.5 Shilpa Medicare Limited Recent Developments/Updates
7.10 Vinkem Labs
7.10.1 Vinkem Labs Oxaliplatin API Company Information
7.10.2 Vinkem Labs Oxaliplatin API Product Portfolio
7.10.3 Vinkem Labs Oxaliplatin API Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Vinkem Labs Main Business and Markets Served
7.10.5 Vinkem Labs Recent Developments/Updates
7.11 Chem Genix
7.11.1 Chem Genix Oxaliplatin API Company Information
7.11.2 Chem Genix Oxaliplatin API Product Portfolio
7.11.3 Chem Genix Oxaliplatin API Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Chem Genix Main Business and Markets Served
7.11.5 Chem Genix Recent Developments/Updates
7.12 Cipla
7.12.1 Cipla Oxaliplatin API Company Information
7.12.2 Cipla Oxaliplatin API Product Portfolio
7.12.3 Cipla Oxaliplatin API Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Cipla Main Business and Markets Served
7.12.5 Cipla Recent Developments/Updates
7.13 Qilu Pharmaceutial
7.13.1 Qilu Pharmaceutial Oxaliplatin API Company Information
7.13.2 Qilu Pharmaceutial Oxaliplatin API Product Portfolio
7.13.3 Qilu Pharmaceutial Oxaliplatin API Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Qilu Pharmaceutial Main Business and Markets Served
7.13.5 Qilu Pharmaceutial Recent Developments/Updates
7.14 VUAB Pharma
7.14.1 VUAB Pharma Oxaliplatin API Company Information
7.14.2 VUAB Pharma Oxaliplatin API Product Portfolio
7.14.3 VUAB Pharma Oxaliplatin API Production, Value, Price and Gross Margin (2020-2025)
7.14.4 VUAB Pharma Main Business and Markets Served
7.14.5 VUAB Pharma Recent Developments/Updates
7.15 Berr Chemical
7.15.1 Berr Chemical Oxaliplatin API Company Information
7.15.2 Berr Chemical Oxaliplatin API Product Portfolio
7.15.3 Berr Chemical Oxaliplatin API Production, Value, Price and Gross Margin (2020-2025)
7.15.4 Berr Chemical Main Business and Markets Served
7.15.5 Berr Chemical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Oxaliplatin API Industry Chain Analysis
8.2 Oxaliplatin API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Oxaliplatin API Production Mode & Process Analysis
8.4 Oxaliplatin API Sales and Marketing
8.4.1 Oxaliplatin API Sales Channels
8.4.2 Oxaliplatin API Distributors
8.5 Oxaliplatin API Customer Analysis
9 Oxaliplatin API Market Dynamics
9.1 Oxaliplatin API Industry Trends
9.2 Oxaliplatin API Market Drivers
9.3 Oxaliplatin API Market Challenges
9.4 Oxaliplatin API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
 Table 1. Global Oxaliplatin API Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global Oxaliplatin API Market Value by Application, (US$ Million) & (2024 VS 2031)
 Table 3. Global Oxaliplatin API Production Capacity (MT) by Manufacturers in 2024
 Table 4. Global Oxaliplatin API Production by Manufacturers (2020-2025) & (MT)
 Table 5. Global Oxaliplatin API Production Market Share by Manufacturers (2020-2025)
 Table 6. Global Oxaliplatin API Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global Oxaliplatin API Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of Oxaliplatin API, Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Oxaliplatin API as of 2024)
 Table 10. Global Market Oxaliplatin API Average Price by Manufacturers (USD/Kg) & (2020-2025)
 Table 11. Global Key Manufacturers of Oxaliplatin API, Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Oxaliplatin API, Product Offered and Application
 Table 13. Global Key Manufacturers of Oxaliplatin API, Date of Enter into This Industry
 Table 14. Global Oxaliplatin API Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Oxaliplatin API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Oxaliplatin API Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global Oxaliplatin API Production Value Market Share by Region (2020-2025)
 Table 19. Global Oxaliplatin API Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global Oxaliplatin API Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global Oxaliplatin API Production Comparison by Region: 2020 VS 2024 VS 2031 (MT)
 Table 22. Global Oxaliplatin API Production (MT) by Region (2020-2025)
 Table 23. Global Oxaliplatin API Production Market Share by Region (2020-2025)
 Table 24. Global Oxaliplatin API Production (MT) Forecast by Region (2026-2031)
 Table 25. Global Oxaliplatin API Production Market Share Forecast by Region (2026-2031)
 Table 26. Global Oxaliplatin API Market Average Price (USD/Kg) by Region (2020-2025)
 Table 27. Global Oxaliplatin API Market Average Price (USD/Kg) by Region (2026-2031)
 Table 28. Global Oxaliplatin API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (MT)
 Table 29. Global Oxaliplatin API Consumption by Region (2020-2025) & (MT)
 Table 30. Global Oxaliplatin API Consumption Market Share by Region (2020-2025)
 Table 31. Global Oxaliplatin API Forecasted Consumption by Region (2026-2031) & (MT)
 Table 32. Global Oxaliplatin API Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America Oxaliplatin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (MT)
 Table 34. North America Oxaliplatin API Consumption by Country (2020-2025) & (MT)
 Table 35. North America Oxaliplatin API Consumption by Country (2026-2031) & (MT)
 Table 36. Europe Oxaliplatin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (MT)
 Table 37. Europe Oxaliplatin API Consumption by Country (2020-2025) & (MT)
 Table 38. Europe Oxaliplatin API Consumption by Country (2026-2031) & (MT)
 Table 39. Asia Pacific Oxaliplatin API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (MT)
 Table 40. Asia Pacific Oxaliplatin API Consumption by Region (2020-2025) & (MT)
 Table 41. Asia Pacific Oxaliplatin API Consumption by Region (2026-2031) & (MT)
 Table 42. Latin America, Middle East & Africa Oxaliplatin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (MT)
 Table 43. Latin America, Middle East & Africa Oxaliplatin API Consumption by Country (2020-2025) & (MT)
 Table 44. Latin America, Middle East & Africa Oxaliplatin API Consumption by Country (2026-2031) & (MT)
 Table 45. Global Oxaliplatin API Production (MT) by Type (2020-2025)
 Table 46. Global Oxaliplatin API Production (MT) by Type (2026-2031)
 Table 47. Global Oxaliplatin API Production Market Share by Type (2020-2025)
 Table 48. Global Oxaliplatin API Production Market Share by Type (2026-2031)
 Table 49. Global Oxaliplatin API Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global Oxaliplatin API Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global Oxaliplatin API Production Value Market Share by Type (2020-2025)
 Table 52. Global Oxaliplatin API Production Value Market Share by Type (2026-2031)
 Table 53. Global Oxaliplatin API Price (USD/Kg) by Type (2020-2025)
 Table 54. Global Oxaliplatin API Price (USD/Kg) by Type (2026-2031)
 Table 55. Global Oxaliplatin API Production (MT) by Application (2020-2025)
 Table 56. Global Oxaliplatin API Production (MT) by Application (2026-2031)
 Table 57. Global Oxaliplatin API Production Market Share by Application (2020-2025)
 Table 58. Global Oxaliplatin API Production Market Share by Application (2026-2031)
 Table 59. Global Oxaliplatin API Production Value (US$ Million) by Application (2020-2025)
 Table 60. Global Oxaliplatin API Production Value (US$ Million) by Application (2026-2031)
 Table 61. Global Oxaliplatin API Production Value Market Share by Application (2020-2025)
 Table 62. Global Oxaliplatin API Production Value Market Share by Application (2026-2031)
 Table 63. Global Oxaliplatin API Price (USD/Kg) by Application (2020-2025)
 Table 64. Global Oxaliplatin API Price (USD/Kg) by Application (2026-2031)
 Table 65. Scion Pharm Taiwan Oxaliplatin API Company Information
 Table 66. Scion Pharm Taiwan Oxaliplatin API Specification and Application
 Table 67. Scion Pharm Taiwan Oxaliplatin API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 68. Scion Pharm Taiwan Main Business and Markets Served
 Table 69. Scion Pharm Taiwan Recent Developments/Updates
 Table 70. Acebright Oxaliplatin API Company Information
 Table 71. Acebright Oxaliplatin API Specification and Application
 Table 72. Acebright Oxaliplatin API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 73. Acebright Main Business and Markets Served
 Table 74. Acebright Recent Developments/Updates
 Table 75. Sai Phytoceuticals Oxaliplatin API Company Information
 Table 76. Sai Phytoceuticals Oxaliplatin API Specification and Application
 Table 77. Sai Phytoceuticals Oxaliplatin API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 78. Sai Phytoceuticals Main Business and Markets Served
 Table 79. Sai Phytoceuticals Recent Developments/Updates
 Table 80. Nischem International Oxaliplatin API Company Information
 Table 81. Nischem International Oxaliplatin API Specification and Application
 Table 82. Nischem International Oxaliplatin API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 83. Nischem International Main Business and Markets Served
 Table 84. Nischem International Recent Developments/Updates
 Table 85. Polymed Therapeutics Oxaliplatin API Company Information
 Table 86. Polymed Therapeutics Oxaliplatin API Specification and Application
 Table 87. Polymed Therapeutics Oxaliplatin API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 88. Polymed Therapeutics Main Business and Markets Served
 Table 89. Polymed Therapeutics Recent Developments/Updates
 Table 90. Fresenius Kabi Oncology Oxaliplatin API Company Information
 Table 91. Fresenius Kabi Oncology Oxaliplatin API Specification and Application
 Table 92. Fresenius Kabi Oncology Oxaliplatin API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 93. Fresenius Kabi Oncology Main Business and Markets Served
 Table 94. Fresenius Kabi Oncology Recent Developments/Updates
 Table 95. Tapi Teva Oxaliplatin API Company Information
 Table 96. Tapi Teva Oxaliplatin API Specification and Application
 Table 97. Tapi Teva Oxaliplatin API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 98. Tapi Teva Main Business and Markets Served
 Table 99. Tapi Teva Recent Developments/Updates
 Table 100. Heraeus Oxaliplatin API Company Information
 Table 101. Heraeus Oxaliplatin API Specification and Application
 Table 102. Heraeus Oxaliplatin API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 103. Heraeus Main Business and Markets Served
 Table 104. Heraeus Recent Developments/Updates
 Table 105. Shilpa Medicare Limited Oxaliplatin API Company Information
 Table 106. Shilpa Medicare Limited Oxaliplatin API Specification and Application
 Table 107. Shilpa Medicare Limited Oxaliplatin API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 108. Shilpa Medicare Limited Main Business and Markets Served
 Table 109. Shilpa Medicare Limited Recent Developments/Updates
 Table 110. Vinkem Labs Oxaliplatin API Company Information
 Table 111. Vinkem Labs Oxaliplatin API Specification and Application
 Table 112. Vinkem Labs Oxaliplatin API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 113. Vinkem Labs Main Business and Markets Served
 Table 114. Vinkem Labs Recent Developments/Updates
 Table 115. Chem Genix Oxaliplatin API Company Information
 Table 116. Chem Genix Oxaliplatin API Specification and Application
 Table 117. Chem Genix Oxaliplatin API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 118. Chem Genix Main Business and Markets Served
 Table 119. Chem Genix Recent Developments/Updates
 Table 120. Cipla Oxaliplatin API Company Information
 Table 121. Cipla Oxaliplatin API Specification and Application
 Table 122. Cipla Oxaliplatin API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 123. Cipla Main Business and Markets Served
 Table 124. Cipla Recent Developments/Updates
 Table 125. Qilu Pharmaceutial Oxaliplatin API Company Information
 Table 126. Qilu Pharmaceutial Oxaliplatin API Specification and Application
 Table 127. Qilu Pharmaceutial Oxaliplatin API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 128. Qilu Pharmaceutial Main Business and Markets Served
 Table 129. Qilu Pharmaceutial Recent Developments/Updates
 Table 130. VUAB Pharma Oxaliplatin API Company Information
 Table 131. VUAB Pharma Oxaliplatin API Specification and Application
 Table 132. VUAB Pharma Oxaliplatin API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 133. VUAB Pharma Main Business and Markets Served
 Table 134. VUAB Pharma Recent Developments/Updates
 Table 135. Berr Chemical Oxaliplatin API Company Information
 Table 136. Berr Chemical Oxaliplatin API Specification and Application
 Table 137. Berr Chemical Oxaliplatin API Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 138. Berr Chemical Main Business and Markets Served
 Table 139. Berr Chemical Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Oxaliplatin API Distributors List
 Table 143. Oxaliplatin API Customers List
 Table 144. Oxaliplatin API Market Trends
 Table 145. Oxaliplatin API Market Drivers
 Table 146. Oxaliplatin API Market Challenges
 Table 147. Oxaliplatin API Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Oxaliplatin API
 Figure 2. Global Oxaliplatin API Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global Oxaliplatin API Market Share by Type: 2024 VS 2031
 Figure 4. Purity ≥ 98 % Product Picture
 Figure 5. Purity ≥ 99 % Product Picture
 Figure 6. Global Oxaliplatin API Market Value by Application, (US$ Million) & (2020-2031)
 Figure 7. Global Oxaliplatin API Market Share by Application: 2024 VS 2031
 Figure 8. Oxaliplatin Injection
 Figure 9. Other
 Figure 10. Global Oxaliplatin API Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Oxaliplatin API Production Value (US$ Million) & (2020-2031)
 Figure 12. Global Oxaliplatin API Production Capacity (MT) & (2020-2031)
 Figure 13. Global Oxaliplatin API Production (MT) & (2020-2031)
 Figure 14. Global Oxaliplatin API Average Price (USD/Kg) & (2020-2031)
 Figure 15. Oxaliplatin API Report Years Considered
 Figure 16. Oxaliplatin API Production Share by Manufacturers in 2024
 Figure 17. Global Oxaliplatin API Production Value Share by Manufacturers (2024)
 Figure 18. Oxaliplatin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. The Global 5 and 10 Largest Players: Market Share by Oxaliplatin API Revenue in 2024
 Figure 20. Global Oxaliplatin API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 21. Global Oxaliplatin API Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 22. Global Oxaliplatin API Production Comparison by Region: 2020 VS 2024 VS 2031 (MT)
 Figure 23. Global Oxaliplatin API Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 24. North America Oxaliplatin API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 25. Europe Oxaliplatin API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 26. China Oxaliplatin API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 27. Japan Oxaliplatin API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 28. Global Oxaliplatin API Consumption by Region: 2020 VS 2024 VS 2031 (MT)
 Figure 29. Global Oxaliplatin API Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 30. North America Oxaliplatin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 31. North America Oxaliplatin API Consumption Market Share by Country (2020-2031)
 Figure 32. U.S. Oxaliplatin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 33. Canada Oxaliplatin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 34. Europe Oxaliplatin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 35. Europe Oxaliplatin API Consumption Market Share by Country (2020-2031)
 Figure 36. Germany Oxaliplatin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 37. France Oxaliplatin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 38. U.K. Oxaliplatin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 39. Italy Oxaliplatin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 40. Russia Oxaliplatin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 41. Asia Pacific Oxaliplatin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 42. Asia Pacific Oxaliplatin API Consumption Market Share by Region (2020-2031)
 Figure 43. China Oxaliplatin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 44. Japan Oxaliplatin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 45. South Korea Oxaliplatin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 46. China Taiwan Oxaliplatin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 47. Southeast Asia Oxaliplatin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 48. India Oxaliplatin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 49. Latin America, Middle East & Africa Oxaliplatin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 50. Latin America, Middle East & Africa Oxaliplatin API Consumption Market Share by Country (2020-2031)
 Figure 51. Mexico Oxaliplatin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 52. Brazil Oxaliplatin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 53. Turkey Oxaliplatin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 54. GCC Countries Oxaliplatin API Consumption and Growth Rate (2020-2031) & (MT)
 Figure 55. Global Production Market Share of Oxaliplatin API by Type (2020-2031)
 Figure 56. Global Production Value Market Share of Oxaliplatin API by Type (2020-2031)
 Figure 57. Global Oxaliplatin API Price (USD/Kg) by Type (2020-2031)
 Figure 58. Global Production Market Share of Oxaliplatin API by Application (2020-2031)
 Figure 59. Global Production Value Market Share of Oxaliplatin API by Application (2020-2031)
 Figure 60. Global Oxaliplatin API Price (USD/Kg) by Application (2020-2031)
 Figure 61. Oxaliplatin API Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools